Here’s what you should know:
1. The European Commission’s probe was in its 16th day as of Oct. 22. The commission is expected to inform Takeda and Shire either formally or informally about the stance of their deal.
2. Both companies expect the deal will earn regulatory approval.
3. Takeda’s $62 billion acquisition will make it one of the world’s largest and most indebted drug makers.
More articles on supply chain:
Optum’s revenues grow to $25.4B in Q3 & more — 8 ASC company key notes
CMS investigating HealthCare.gov data breach affecting 75K individuals
New York ASC partners with payer to deliver region’s 1st outpatient hip replacements
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
